XML 26 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statement of Cash Flows (USD $)
12 Months Ended 58 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (1,516,309) $ (1,026,433) $ (4,892,107)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 32,500 32,500 135,415
Change in allowance for uncollectible notes receivable 13,867 25,000 38,867
Amortization of deferred finance costs 1,252 32,240 33,492
Interest expense on fair value adjustments of convertible notes payable 59,280 137,286 247,929
Write-off of uncollectible deposit     20,000
Accrued interest on notes receivable     (11,705)
Loss on extinguishment of debt 297,796 46,120 343,916
Loss on impairment 21,000 0 21,000
Stock issued for services 605,334 319,070 1,752,027
Changes in operating assets and liabilities:      
Increase decrease Prepaid expenses (43,860)   (43,860)
Increase decrease Deposits and other receivables   3,638 (23,346)
Increase decrease Accounts payable and accrued liabilities 33,960 (11,686) 244,667
Net cash used in operating activities (495,180) (442,265) (2,133,706)
CASH FLOWS FROM INVESTING ACTIVITIES      
Principal payments from notes receivable (25,000)   (25,000)
Purchase of common stock (21,000) (1,100) (22,100)
Acquisition of equipment (325,000)   (325,000)
Net cash provided by (used in) investing activities (21,000) (1,100) (372,100)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from the issuance of common stock 297,172 233,196 1,789,144
Proceeds from the issuance of convertible notes and convertible notes payable 261,000 246,000 801,800
Payments on notes and convertible notes payable (31,000) (10,000) (81,000)
Proceeds from loans from stockholders 2,225 2,225 35,925
Payments on stockholder loans 5,225 (26,000) (31,225)
Net cash provided by financing activities 532,397 445,421 2,514,644
CHANGE IN CASH 5,767 2,056 8,838
CASH, BEGINNING OF PERIOD 3,071 1,015  
CASH, ENDING OF PERIOD 8,838 3,071 8,838
NONCASH OPERATING AND FINANCING ACTIVITIES:      
Due to Organetix, Inc. reclassified to additional paid-in capital 91,500   91,500
Common stock issued to satisfy minimum value guarantee   129,000 87,667
Convertible debt converted to common stock including accrued interest 540,524 314,705 978,262
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:      
Cash paid for Interest $ 3,660   $ 3,660